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Abstract
Background: Non-adherence to treatment has been identified as the main cause of uncontrolled blood pressure (BP), and 
may rep-resent a greater risk in older individuals. 
Objective: The aim of this study was to evaluate and compare the rate of adherence to hypertension treatment 
using different methods, to estimate the BP control rate, and to observe if there is an association between BP 
control and adherence. 
Methods: Treatment adherence was evaluated in older patients with hypertension, followed by the public primary health 
care, through four methods, including the Morisky-Green test (reference), the Attitude regarding the Medication Intake 
questionnaire (AMI), an evaluation of adherence by the nurse in the office (Nurse Adherence Evaluation - NAE), and at 
home (Home Adherence Evaluation – HAE). Salt intake was estimated by 24-hour sodium urinary excretion. BP control was 
assessed by the awake ambulatory blood pressure monitoring. 
Results: Concordance between the Morisky-Green test and AMI (Kappa=0.27) or NAE (Kappa=0.05) was poor. There was 
a moderate concordance between the Morisky-Green test and HAE. Eighty percent had controlled BP, including 42% with 
white-coat effect. The group with lower salt excretion informed to avoid salt intake more times (p<0.001) and had better 
medication adherence (p<0.001) than the higher salt excretion group. 
Conclusion: The evaluated tests did not show a good concordance to the Morisky-Green test. Adherence to hypertension 
treatment was low; however, there was a high rate of BP control when subjects with the white-coat effect were included in 
the analysis. (Arq Bras Cardiol 2012;99(1):636-641)
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Introduction
The prevalence of hypertension in older subjects is higher 
than 60% and the correct diagnosis and unremitting patients’ 
follow-up are very important keys to achieve the ideal goal of 
treatment and reduce cardiovascular morbidity and mortality.
Adherence to treatment, defined as the correct following 
of the physician’s prescription,1 including medications and/
or changes in life style, is a significant factor of the treatment 
success. Non-adherence has been identified as the main 
cause of uncontrolled blood pressure (BP)2, thus representing 
a meaningful risk to cardiovascular events. The correct intake 
of at least 80% of prescribed medications it is a general way to 
consider adequate drug adherence2. The estimated adherence 
to medications is around 50%3, and this rate decreases even 
further regarding life style changes4. 
Evaluation of adherence is not standardized, turning into 
a hard task any comparisons. Direct methods as biological 
assays, or directly observed therapy (DOT) are difficult to 
apply, expensive, and not exempted of errors5. Among 
indirect methods, the Morisky-Green test is a simple validated 
instrument to estimate adherence to the treatment6. It 
comprises four questions to be answered with ‘yes’ or ‘no’ 
and, although it is not an ideal method, it has been the most 
used one in previous studies about adherence to the treatment 
of chronic diseases and can be accepted as a reference test. 
The original study showed that seventy-five percent of the 
hypertensive patients who scored high on the four-item scale 
after two years of follow up had their blood pressure under 
adequate control at year 5, compared with 47% under control 
at year 5 for those patients scoring low (P less than 0.01)6.
The aims of this study were to evaluate and compare 
adherence rates to the treatment of hypertension of older 
patients in primary health care using the Morisky-Green test 
and three non-validated indirect methods; to estimate the 
rate of BP control; and to observe if there is an association 
between BP control and adherence.
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Methods
Sixty older patients (60 years-old or more) followed by the 
public primary health care, who filled all inclusion criteria, 
were invited to participate: one to eight years of formal 
education, hypertension in regular treatment, no evidence of 
secondary hypertension, in use of more than four medications 
per day, no use of medications that could interfere on BP 
control, no cognitive deficits (Mini-Mental State Examination 
with score higher than 24 points)7 and independents (Barthel 
Index with score of 20 points)8. This study was performed 
in accordance with the Declaration of Helsinki (1989) and 
approved by the local Human Research Ethics Committee. 
Informed consent was obtained from each volunteer. 
An oral questionnaire was applied by a trained nurse to 
collect information about the duration of disease, number 
of medications in use, knowledge about hypertension risks, 
difficulties to obtain the medications, problems to take them 
in a regular way, including side effects and the prescription 
perception. Alcohol consumption, cigarette smoking, salt 
intake, and physical activity were also evaluated.
BP was measured three times in the office by a trained 
nurse, in the seated position9. After one week, this procedure 
was repeated. Volunteers were also submitted to one 
ambulatory blood pressure monitoring (ABPM, Spacelabs 
90207, Redmond, Washington, USA) and were considered 
controlled when the mean BP, during the period of awake, 
was lower than 135/85 mmHg10. When awake ABPM was 
controlled and Office BP was equal or higher 140x90 mmHg, 
the patient was classified as having the white coat effect. When 
the Office BP was lower than 140x90 mmHg and awake ABPM 
was equal or higher 135/85 mmH, the patient was classified 
as having false control. 
A 12-hour fasting blood sample was drawn for the 
determination of plasma glucose, total cholesterol, HDL-
cholesterol, triglycerides, creatinine, and potassium 
concentrations. 
Thirty-three patients were randomly assigned to perform 
the adherence tests: 
1.  Morisky-Green test:6 it comprises four yes/no questions: 
(1) Have you ever forgotten to take your medicine? (2) At 
times, are you not careful about taking your medicine? (3) 
When you feel better, do you sometimes stop taking your 
medicine? (4) At times, if you feel worse when you take your 
medicine, do you stop taking them? A person was considered 
to be non-adherent whether he/she responded affirmatively 
to at least one question. 2. Attitude regarding the Medication 
Intake questionnaire (AMI). 3. Nurse Adherence Evaluation 
(NAE): evaluation of adherence by the nurse in the office. 
4. Home Adherence Evaluation (HAE): adherence to the 
treatment was estimated by the availability of medications 
for hypertension and by the information given by the patient 
simulating the intake of them.   BP was measured three times 
by the nurse (Home BP). The patient was considered adherent 
by the last three tests if had a correct intake of 80% or more 
of the total hypertension medications. 
Two 24-hour urine specimens were collected for urinary 
sodium excretion (UNaV) determination, and the mean excretion 
was considered an estimate of the amount of sodium intake. 
BP means obtained were compared through a unified 
approach to mixed linear models11. The Fisher’s exact test 
was used to compare qualitative data between groups. 
The Kappa Index was applied to evaluate the degree of 
concordance12. The following categorization was adopted: 
less than zero: poor; 0.00-0.20: slight; 0.21-0.40: fair; 
0.41-0.60: moderate; 0.61-0.80: substantial; and 0.81-
1.00: almost perfect. Statistical analysis: performed by the 
employment of the SAS/STAT® software, Version 9, Cary, 
NC, USA: SAS Institute Inc., 2002-2003. The adopted level 
of significance was p<0.05. Data are expressed as mean 
± standard deviation.
This study was supported by FAEPA – Faculdade de 
Medicina de Ribeirão Preto – Universidade de São Paulo.
Results
The mean age was 71±6 years, with 3.7±1.8 years of 
formal education, 63% female, 60% white, 63% married, 68% 
retired, 65% living with a partner, 60% with familiar income 
from US$ 175.00 to US$ 524.00, with 1.8±1.2 dependents. 
Thirty-three percent had diabetes, 42% hyperlipidemia, 
and 10% both. All volunteers had normal values of plasma 
creatinine and potassium. The mean BMI was 26.4±3.9 Kg/
m2, 17% with degree I obesity. 
Eighty-eight percent were conscious of the hypertension 
diagnosis, and 72% informed to know the duration of their 
disease (mean of 11.6±8.2 years). Twenty percent did not 
know that hypertension increases the risk to cardiovascular 
morbidity and mortality, and 42% believed in the cure of 
essential hypertension.
The patients reported an intake of 4.5±2.3 medications/
day. However, there were 6.1±2.0 prescribed drugs 
(p<0.001). Considering only anti-hypertensive medications, 
the numbers were 1.2±0.8 and 1.9±0.4, respectively 
(p<0.001). Fifty-eight percent of the subjects mentioned 
medication interruption because of adverse effects and 40% 
had adverse effects associated to the medications at that 
moment. Forty-eight percent informed that frequently forgot 
one of the prescribed medications. 
Patients with controlled BP knew the time of hypertension 
diagnosis more frequently than uncontrolled ones (75% vs. 
42%, p=0.04). 
Regarding the prescription, 78% of the volunteers reported 
they did not understand the physician handwriting. Problems 
to obtain the medications were rarely described. Two subjects 
were in use of tobacco, and 11% in alcohol intake (750 ml of 
beer per week). Regular physical activity was reported by 43%, 
mainly walking and gym, although 90% mentioned previous 
physician advice about the importance of exercises. Fifty 
percent commented that they avoided salt and 42%, fat food. 
The results of all BP measuring are showed in Table 1, 
with lower BP obtained by awake ABPM than by the nurse 
(p<0.05). Forty-two percent of the patients had the white-coat 
effect, 7% had a false control, 13% were not controlled, and 
38% had controlled hypertension. Considering the last group 
and patients with the white coat effect together, the rate of 
BP control was 80%.
637
Original Article
Arq Bras Cardiol 2012;99(1):636-641
Bastos-Barbosa et al.
Treatment adherence and blood pressure control
There were no differences in BP control between adherent 
and non-adherent patients, considering the results obtained 
by ABPM during the period of awake and the Morisky-Green 
test (p=0.61).
According to the Morisky-Green test, 36% of the subjects 
were adherent. However, 64% had positive attitudes regarding 
medications intake. In the HAE, 52% of them were in use 
of 80% or more of the anti-hypertensive drugs prescribed, 
similarly to the 55% found in the NAE.  
The concordance between the Morisky-Green test and the 
AMI or the NAE was poor. There was a moderate concordance 
between the Morisky-Green test and the HAE (Table 2). 
The mean 24-hour UNaV was 170±60 mmol/day. When 
patients that had a 24-hour UNaV equal or lower than 150 
mmol/day and those with UNaV higher than 150 mmol/day 
were compared, the first group mentioned more times to avoid 
salt intake (p<0.001) and had better medication adherence 
evaluated by the Morisky-Green test (p<0.001) - Table 3. The 
urinary potassium excretion was 46±17 mmol/day. 
Discussion
In this study, 42% of the studied older individuals were not 
conscious of the chronic characteristic of hypertension. Other 
study, evaluating adults in primary health services, found the 
percentage of 19% regarding this same issue13. This also found 
that patients with controlled hypertension better knew the 
disease duration than uncontrolled ones. 
Almost half of the subjects reported to forget the 
medications intake and had adverse effects. There were 
divergent numbers of medications mentioned by the patients 
and prescribed, considering all drugs and anti-hypertensive 
ones only. The higher the number of medications prescribed, 
the higher the risk of potential dangerous interactions and 
adverse effects, resulting in low adherence to the treatment14. 
Older patients have a mean number of around four to six 
medications in use15. This study selected patients with more 
than four medications, because this is the usually observed 
condition. One of the most important strategies to improve 
adherence in hypertension treatment is to simplify the 
treatment. Nevertheless, older patients have more chronic 
conditions, and many times, it is not possible to reduce the 
number of medications.
The majority of the patients were not able to read the 
physician prescription because of unclear handwriting. A 
prospective Brazilian study with 1,227 patients showed that 
all prescriptions were handwritten and that only 24% had 
legible names of medications, what could lead to serious 
intake mistakes16. Lower understanding of prescriptions 
was found among older patients and people with lower 
socioeconomic state. In developed countries older patients 
also had a greater prevalence of problems related to 
Table 1 -  BP of older individuals at the first (Office BP1) and at the second (Office BP2) nurse evaluation, the mean of them, the BP measured 
by ambulatory blood pressure monitoring during awake period (Awake ABPM), and BP obtained by nurse at home (Home BP) (mean±SD)
SBP 
(mmHg)
DBP
(mmHg)
Office BP1 (n=60) 144 ± 22 82 ± 12
Office BP2 (n=60) 139 ± 23 81 ± 13
Mean Office BP  (n=60) 142 ± 22 82 ± 12
Awake ABPM (n=60) 126 ± 15* 72 ± 10*
*p<0.05 vs. Office BP1, Office BP2, Mean Office BP and Home BP (Mixed linear models).
Table 2 - Degree of concordance between the Morisky-Green test and three indirect methods: Attitude regarding the Medication Intake (AMI), 
Home Adherence Evaluation (HAE), and Nurse Adherence Evaluation (NAE), in hypertensive older individuals
Morisky & Green
Adherent Non-Adherent Total Kappa IC 95%
AMI
Positive attitude 10 11 21 0.27 (-0.01;0.54)
Negative attitude
HAE
Adherent
Non-Adherent
NAE
Adherent
Non-Adherent
2
10
2   
7
5
10
7
14
11
10
12
17
16
18
15
0.46
0.05
(0.17;0.75)
(-0.26;0.37)
Kappa coefficient - less than zero: poor; 0.00-0.20: slight; 0.21-0.40: fair; 0.41-0.60: moderate; 0.61-0.80: substantial; and 0.81-1.00: almost perfect.
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the form of prescriptions17. Electronic prescriptions can 
minimize risks.
In Brazil, the SUS (Unified Health System), the official public 
health provider, delivers basic hypertension drugs under no costs 
to the whole population. In this study the volunteers informed 
no difficulties in obtaining the prescribed medications.
There was not good concordance between the Morisky-
Green test and the other ones applied. Similar discordance was 
referred by Solera et al, who found an adherence rate of 38% 
using a clinic interview and 91.1% with the Morisk-Greeen 
test in hypertensive patients with mean age of 66±1218. The 
evaluation of adherence at home, where the nurse was able 
to check medications by herself, had better concordance with 
the Morisky-Green test than the AMI and the NAE, which 
are based only in patient information. Maybe it was the most 
reliable test applied in this study.
The low adherence obtained in this study can be explained 
by the selection of patients that were in use of more than 
four medications, had low income and adverse effects. 
Observational studies showed lower rates of adherence among 
older hypertensive patients than among younger ones19. 
Previous studies with older patients found 51%20 and 23%21 of 
adherence using the Morisky-Green test. On the other hand, 
the Morisky-Green test can overestimate poor adherence22.
It was unexpected that, although the older individuals had a 
low adherence, they had a good BP control when evaluated by 
the ABPM. Older subjects had a high prevalence of the white 
coat effect, which can only be detected by methods with no 
health professional contact23. No association between the BP 
control and good adherence was found. It can be supposed 
that the subjects were in good control of BP with the intake 
of fewer medications than prescribed, maybe because the 
physicians were underestimating the BP control. 
More than half of the subjects had no adherence to physical 
activity, even though the majority had received adequate 
advice about its importance. Physical activity helps to control 
cardiovascular risk factors and reduces BP independently of 
the weight loose effect24.
The est imated sodium intake was higher than 
recommended9. Individuals with an intake of 150 mmol per 
day or less, that can be considered as on a normal sodium 
diet, referred more times they avoided salt and had a higher 
rate of BP control than who had higher sodium intake. Salt 
restriction is very important to achieve BP control. There was 
an extra systolic BP decrease of 7.1 mmHg in normotensive 
people and 11.5 mmHg in hypertensive ones,25 when it was 
associated to the DASH diet26.
The estimated intake of potassium was adequate comparing 
to the INTERSALT Study27. One randomized double-blind study 
with 100 hypertensive older individuals concluded that a diet 
with lower salt and higher potassium and magnesium content 
promoted BP reduce28. Whelton et al29 evaluated 975 older 
hypertensive patients and showed that the reduction of salt 
intake and body weight were effective and safety interventions.
 
Conclusions
This study showed that the three adherence tests evaluated 
have no good concordance to the validated Morisky-Green 
test. Adherence to the hypertension treatment was low in 
this old group followed in primary care; however, there was 
a good rate of BP control when subjects with the white-coat 
effect were detected by the ABPM. 
Acknowledgements
The authors are indebted to CEMEQ - Ribeirão Preto 
Medical School, for assistance with the statistical analysis.
Potential Conflict of Interest
No potential conflict of interest relevant to this article was 
reported.
Sources of Funding
This study was partially funded by FAEPA - FMRP - USP.
Study Association
This article is part of the thesis of master submitted by 
Rachel Gabriel Bastos-Barbosa, from Faculdade de Medicina 
e Faculdade de Ciências Farmacêuticas Ribeirão Preto - USP.
Table 3 - Distribution of hypertensive older individuals regarding the 24-hour urinary sodium excretion (UNaV), the reference of avoid salt 
intake or not, and the result of the Morisky-Green test
UNaV<150 mmol/day UNaV >150 mmol/day
Variable N % N % pa
Avoid salt
Yes 7 53.8% 7 35.0% <0.001
No 6 46.2% 13 65.0%
Morisky & Green
Adherent 6 46.2% 6 30.0% <0.001
Non-adherent 7 53.8% 14 70.0%
a Fischer’s exact test
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